SCHEMBL6606938

SCHEMBL6606938

CN(Cc1ccccc1)c1ccc(N)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.54
NR1H3 Q13133 1/20 0.54
AOC3 Q16853 1/20 0.52
ALDH1A1 P00352 3/20 0.50
TSHR P16473 2/20 0.50
CRHBP P24387 1/20 0.49
CRHR2 Q13324 1/20 0.49
MAOB P27338 4/20 0.48
MAOA P21397 2/20 0.48
CYP3A4 P08684 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
CYP2C19 P33261 2/20 0.48
KDM4E B2RXH2 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2D6 P10635 1/20 0.48
MAPT P10636 1/20 0.48
CYP2C9 P11712 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
TP53 P04637 1/20 0.46
ALOX15 P16050 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24124892 0.92 CRHBP (0.57) NR1H2NR1H3AOC3ALDH1A1TSHR
SCHEMBL11881187 0.89 NR1H2 (0.62) NR1H2NR1H3AOC3ALDH1A1TSHR
SCHEMBL14998228 0.87 HDAC3 (0.53) NR1H2NR1H3ALDH1A1CRHBPCRHR2
SCHEMBL642317 0.85 CRHBP (0.61) NR1H2NR1H3AOC3ALDH1A1TSHR
Hydrochloric Acid SCHEMBL27388371 0.83 CRHBP (0.59) NR1H2NR1H3AOC3ALDH1A1TSHR
SCHEMBL8228982 0.82 CYP2C19 (0.68) NR1H2NR1H3AOC3ALDH1A1TSHR
SCHEMBL4403042 0.82 NR1H2 (0.56) NR1H2NR1H3AOC3ALDH1A1TSHR
Nitrogen SCHEMBL4600396 0.81 CRHBP (0.58) NR1H2NR1H3AOC3ALDH1A1TSHR
SCHEMBL2392177 0.81 CYP3A4 (0.47) NR1H2NR1H3ALDH1A1TSHRCYP3A4
SCHEMBL25839380 0.81 NR1H2 (0.51) NR1H2NR1H3AOC3ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3147333-A1 DISPERSE DYE COMPOSITION, DISPERSE DYE AND PREPARATION METHOD AND USE THEREOF Zhejiang Runtu Co., Ltd. (CN) 2017-03-29 EP disclosed
US-20040198731-A1 Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2004-10-07 US disclosed
US-20040198732-A1 Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2004-10-07 US disclosed
US-20040198733-A1 Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2004-10-07 US disclosed
US-20040192693-A1 Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2004-09-30 US disclosed
EP-1418906-A1 AMINOALKYL-SUBSTITUTED AROMATIC BICYCLIC COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS Aventis Pharma Deutschland GmbH (DE) 2004-05-19 EP disclosed
US-20030212070-A1 Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-11-13 US disclosed
WO-2003015769-A1 AMINOALKYL-SUBSTITUTED AROMATIC BICYCLIC COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-02-27 WO disclosed
EP-0173932-A2 Hair dyeing composition Henkel Kommanditgesellschaft auf Aktien (DE) 1986-03-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030212070-A1 Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals PER2, CNR2, DDC NR1H2 35/4885NR1H3 50/4885AOC3 1031/4885
US-20040192693-A1 Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals PER2, CNR2, DDC NR1H2 35/4885NR1H3 50/4885AOC3 1031/4885
US-20040198731-A1 Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals PER2, CNR2, DDC NR1H2 35/4885NR1H3 50/4885AOC3 1031/4885
US-20040198733-A1 Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals PER2, CNR2, DDC NR1H2 35/4885NR1H3 50/4885AOC3 1031/4885
US-20040198732-A1 Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals PER2, CNR2, DDC NR1H2 35/4885NR1H3 50/4885AOC3 1031/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.